120 related articles for article (PubMed ID: 27915255)
1. Theoretical and experimental evidence for eliminating persister bacteria by manipulating killing timing.
Cogan NG; Rath H; Kommerein N; Stumpp SN; Stiesch M
FEMS Microbiol Lett; 2016 Dec; 363(23):. PubMed ID: 27915255
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease.
Conlon BP
Bioessays; 2014 Oct; 36(10):991-6. PubMed ID: 25100240
[TBL] [Abstract][Full Text] [Related]
3. Influence of sub-inhibitory antibiotics and flow condition on Staphylococcus aureus ATCC 6538 biofilm development and biofilm growth rate: BioTimer assay as a study model.
Berlutti F; Frioni A; Natalizi T; Pantanella F; Valenti P
J Antibiot (Tokyo); 2014 Nov; 67(11):763-9. PubMed ID: 24865865
[TBL] [Abstract][Full Text] [Related]
4. msaABCR operon is involved in persister cell formation in Staphylococcus aureus.
Sahukhal GS; Pandey S; Elasri MO
BMC Microbiol; 2017 Nov; 17(1):218. PubMed ID: 29166860
[TBL] [Abstract][Full Text] [Related]
5. Multidrug tolerance of biofilms and persister cells.
Lewis K
Curr Top Microbiol Immunol; 2008; 322():107-31. PubMed ID: 18453274
[TBL] [Abstract][Full Text] [Related]
6.
Theis TJ; Daubert TA; Kluthe KE; Brodd KL; Nuxoll AS
Front Cell Infect Microbiol; 2023; 13():1178526. PubMed ID: 37228667
[TBL] [Abstract][Full Text] [Related]
7. Combatting bacterial infections by killing persister cells with mitomycin C.
Kwan BW; Chowdhury N; Wood TK
Environ Microbiol; 2015 Nov; 17(11):4406-14. PubMed ID: 25858802
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic-tolerant Staphylococcus aureus Biofilm Persists on Arthroplasty Materials.
Urish KL; DeMuth PW; Kwan BW; Craft DW; Ma D; Haider H; Tuan RS; Wood TK; Davis CM
Clin Orthop Relat Res; 2016 Jul; 474(7):1649-56. PubMed ID: 26831479
[TBL] [Abstract][Full Text] [Related]
10. pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms.
Lebeaux D; Chauhan A; Létoffé S; Fischer F; de Reuse H; Beloin C; Ghigo JM
J Infect Dis; 2014 Nov; 210(9):1357-66. PubMed ID: 24837402
[TBL] [Abstract][Full Text] [Related]
11. Stochastic Variation in Expression of the Tricarboxylic Acid Cycle Produces Persister Cells.
Zalis EA; Nuxoll AS; Manuse S; Clair G; Radlinski LC; Conlon BP; Adkins J; Lewis K
mBio; 2019 Sep; 10(5):. PubMed ID: 31530676
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-Produced Peroxynitrite Induces Antibiotic Tolerance and Supersedes Intrinsic Mechanisms of Persister Formation.
Beam JE; Wagner NJ; Shook JC; Bahnson ESM; Fowler VG; Rowe SE; Conlon BP
Infect Immun; 2021 Sep; 89(10):e0028621. PubMed ID: 34097475
[TBL] [Abstract][Full Text] [Related]
13. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic tolerance and the alternative lifestyles of
Bui LM; Conlon BP; Kidd SP
Essays Biochem; 2017 Feb; 61(1):71-79. PubMed ID: 28258231
[No Abstract] [Full Text] [Related]
15. Design, synthesis and biological evaluation of novel hamamelitannin analogues as potentiators for vancomycin in the treatment of biofilm related Staphylococcus aureus infections.
Vermote A; Brackman G; Risseeuw MDP; Coenye T; Van Calenbergh S
Bioorg Med Chem; 2016 Oct; 24(19):4563-4575. PubMed ID: 27507109
[TBL] [Abstract][Full Text] [Related]
16. Modelling protection from antimicrobial agents in biofilms through the formation of persister cells.
Roberts ME; Stewart PS
Microbiology (Reading); 2005 Jan; 151(Pt 1):75-80. PubMed ID: 15632427
[TBL] [Abstract][Full Text] [Related]
17. XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms.
Ooi N; Miller K; Randall C; Rhys-Williams W; Love W; Chopra I
J Antimicrob Chemother; 2010 Jan; 65(1):72-8. PubMed ID: 19889790
[TBL] [Abstract][Full Text] [Related]
18. [Monitoring of the resistance to antibiotics of Staphylococcus aureus strains isolated from out-patients].
Văduva DB; Licker M; Dumitraşcu V; Văduva MB; Velimirovici D; Linţa M; Horhat F; Orb CE; Crăciunescu M; Branea D; Hogea E; Horhat D; Moldovan R
Bacteriol Virusol Parazitol Epidemiol; 2005; 50(1-2):41-8. PubMed ID: 17300030
[No Abstract] [Full Text] [Related]
19. Activated ClpP kills persisters and eradicates a chronic biofilm infection.
Conlon BP; Nakayasu ES; Fleck LE; LaFleur MD; Isabella VM; Coleman K; Leonard SN; Smith RD; Adkins JN; Lewis K
Nature; 2013 Nov; 503(7476):365-70. PubMed ID: 24226776
[TBL] [Abstract][Full Text] [Related]
20. High persister cell formation by clinical
Liu L; Wang Y; Bojer MS; Andersen PS; Ingmer H
Microbiology (Reading); 2020 Jul; 166(7):654-658. PubMed ID: 32427093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
